Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations

Month: July 2025

Home » Archives for July 2025 » Page 12
Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer

Novel Advances in Anti-Angiogenic Therapy for Advanced Gastric Cancer

Posted by By Lisa Cui 2025.07.01
Read More
Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Identification and Management of Secondary Resistance to Anti-Angiogenic Therapy in Metastatic Colorectal Cancer

Posted by By Ren Jiamo 2025.07.01
Read More
Early research, clinical practice and thinking of innovative NK cell therapy

Early research, clinical practice and thinking of innovative NK cell therapy

Posted by By Mourabit Halima 2025.07.01
Read More
Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Clinical and Translational Research on Gastric Cancer Based on Molecular Typing

Posted by By Peng Longmei 2025.07.01
Read More
Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Research Progress of Artificial Intelligence in the Field of Digestive System Tumors

Posted by By Mourabit Halima 2025.07.01
Read More
Enhancing CAR T Therapy toTarget Solid Tumors

Enhancing CAR T Therapy toTarget Solid Tumors

Posted by By El Bachir MOURABIT 2025.07.01
Read More

Posts pagination

Previous page 1 … 10 11 12
Recent Posts
  • CSCO DocX TALK | Upholding Core Principles and Driving Innovation: Professor Heinz-Josef Lenz and HUTCHMED Discuss the Globalization of China’s Innovative Oncology Drugs
  • Professor Li Wang: First-Line Treatment Landscape and Controversies in MCL in the BTK Inhibitor Era | 2026 China-France Scientific Symposium on Hematology and Immunology
  • September 2 – Roundtable Discussion
  • Getting to the Bottom of the Debate 2.0 | Metastatic Renal Cell Carcinoma: Extrapolating Second-Line Evidence and Individualizing First-Line Dual Immunotherapy Versus Immunotherapy–TKI Combinations—A Debate Between Professors Xuewen Jiang and Hailiang Zhang
  • Getting to the Bottom of the Debate 2.0 | Oligoprogressive mCRPC: Debating Local Therapy and the Sequencing of PARP Inhibitors and ¹⁷⁷Lu-PSMA-617—A Debate Between Professors Jianming Guo and Qing Zou
Recent Comments
    Archives
    • October 2026
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top